Clinical Trial Update: S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction [Phase 2]

View source ↗

Summary

A Phase 2 SWOG trial evaluating a multimodal regimen of oxaliplatin, 5-fluorouracil, radiation therapy, and surgery for stage II-III esophageal or gastroesophag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-04-03